Startide Sciences was an venture capital firm that used to invest in the disease research, proteomics research, genetic analysis, drug discovery and development, pharmacogenomics, clinical diagnostics and cellular analysis sectors. The firm was founded in 2014 and was based in Bellevue, Washington .